Medicare drug coverage

Camzyos: 2027 Medicare Part D coverage

363 of 5,495 Part D plans (7%) list Camzyos on their 2027 formulary, down 20 points from 2026. 100% of those require prior authorization, step therapy, or a quantity limit.

License. US government work, Public Domain Mark 1.0.

2027 compared with 2026

Camzyos is number 145 by total Medicare Part D spending in 2024 ($291 million). Plans that list it most often put it on tier 5. Counts use 5 RxNorm products for this name.

Camzyos Part D coverage, 2026 and 2027
Measure20262027Change
Part D plans in the file5,5185,495-23
Plans that list it1,489 (27%)363 (7%)-20 points
Prior authorization (of plans that list it)1,489 (100%)363 (100%)no change
Step therapy (of plans that list it)0 (0%)0 (0%)no change
Quantity limit (of plans that list it)1,481 (99%)363 (100%)+1 point
Any of the three (of plans that list it)1,489 (100%)363 (100%)no change
Not listed or restricted (of all plans)5,518 (100%)5,495 (100%)no change

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Formulary tier

Camzyos formulary tier, 2026 and 2027
Tier2026 plans2027 plans
Tier 145 (3%)8 (2%)
Tier 22 (0%)1 (0%)
Tier 415 (1%)12 (3%)
Tier 51,407 (94%)342 (94%)
Tier 620 (1%)0 (0%)

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Plan by plan, 2026 to 2027

4,380 plan ids are in both files. 0 of them (0%) added prior authorization, step therapy, or a quantity limit for Camzyos, and 899 stopped listing it.

Camzyos: plans in both 2026 and 2027
Plan by planPlans
Same plan id in both years4,380
Listed it in 2026, not in 2027899 (21%)
Listed it in 2027, not in 202611 (0%)
Moved it to a higher tier3 (0%)
Added prior authorization0 (0%)
Added step therapy0 (0%)
Added a quantity limit0 (0%)
Added at least one of the three0 (0%)
Removed at least one of the three0 (0%)
Plan ids new in 20271,115
2026 plan ids not in the 2027 file1,138

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

States from most to least restrictive

Share of 2027 Part D plans offered in each state that leave Camzyos off the formulary or list it with prior authorization, step therapy, or a quantity limit. Alabama ranks first at 100%, with 16% of its plans using prior authorization or step therapy; Kansas ranks last at 100%. Ties break on the prior authorization or step therapy share.

States from most to least restrictive for Camzyos, 2027
RankState2027 plansNot listed or restrictedPrior auth or step therapyChange from 2026
1Alabama115100%16%no change
2Ohio173100%16%no change
3Georgia151100%13%no change
4Arkansas86100%13%no change
5Illinois133100%13%no change
6South Carolina91100%12%no change
7Mississippi105100%11%no change
8Alaska9100%11%no change
9Louisiana126100%10%no change
10Tennessee157100%10%no change
11North Carolina177100%10%no change
12Delaware43100%9%no change
13Michigan183100%8%no change
14Missouri171100%8%no change
15Maryland49100%8%no change
16Texas412100%8%no change
17Wyoming13100%8%no change
18Colorado106100%8%no change
19Vermont14100%7%no change
20West Virginia70100%7%no change
21Massachusetts92100%7%no change
22Oklahoma81100%6%no change
23Arizona148100%6%no change
24Kentucky123100%5%no change
25District of Columbia21100%5%no change
26New Mexico68100%4%no change
27New York215100%4%no change
28New Jersey74100%4%no change
29New Hampshire25100%4%no change
30North Dakota26100%4%no change
31Montana27100%4%no change
32Pennsylvania324100%4%no change
33Washington114100%4%no change
34Rhode Island29100%3%no change
35South Dakota30100%3%no change
36Wisconsin97100%3%no change
37Nevada100100%3%no change
38Virginia145100%3%no change
39Idaho45100%2%no change
40Oregon92100%2%no change
41Indiana140100%2%no change
42Florida549100%2%no change
43Hawaii50100%2%no change
44Nebraska51100%2%no change
45Maine52100%2%no change
46Utah53100%2%no change
47Connecticut54100%2%no change
48Minnesota63100%2%no change
49Iowa64100%2%no change
50California397100%2%no change
51Kansas84100%1%no change

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

By parent organization

164 parent organizations offer 2027 Part D plans. Humana Inc. has the most, 884, and 100% of them leave Camzyos off or restrict it.

Camzyos coverage by parent organization, 2027
Parent organization2027 plans ↑List itRestrict it (of listing)Not listed or restrictedChange from 2026Plans that added a restriction
AIDS Healthcare Foundation10%none list it100%no change0
Alameda Alliance for Health10%none list it100%no change0
AllCare Health, Inc.10%none list it100%no change0
AlohaCare10%none list it100%no change0
BCBS MN, MT, NE, ND, WY, Wellmark IA and SD10%none list it100%no change0
CareOregon, Inc.1100%100%100%no change0
Contra Costa Health Services10%none list it100%no change0
DLP Marquette Health Plan, LLC1100%100%100%no change0
Health Plan of San Mateo1100%100%100%no change0
IMPERIAL COUNTY LOCAL HEALTH AUTHORITY10%none list it100%no change0
INLAND EMPIRE HEALTH PLAN10%none list it100%no change0
Itasca County10%none list it100%no change0
Kern Health Systems (KHS)10%none list it100%no change0
Local Initiative Health Authority for LA County10%none list it100%no change0
Muscogee Creek Nation10%none list it100%new in 20270
Orange County Health Authority1100%100%100%no change0
SAN FRANCISCO HEALTH AUTHORITY10%none list it100%no change0
SAN JOAQUIN COUNTY HEALTH COMMISSION10%none list it100%no change0
SANTA BARBARA SAN LUIS OBISPO REGIONAL HEALTH AUTH10%none list it100%no change0
SANTA CLARA COUNTY HEALTH AUTHORITY10%none list it100%no change0
SANTA CRUZ MONTEREY MERCED SAN BENITO MARIPOSA MAN10%none list it100%no change0
Samaritan Health Services, Inc.10%none list it100%no change0
The Schroer Group, Inc.10%none list it100%no change0
Ventura County Medi-Cal Managed Care Commission10%none list it100%no change0
BayCare Health System, Inc.20%none list it100%no change0

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Run it in Rivvi

Which 2027 plans near you dropped or restricted Camzyos?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan, before open enrollment.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Near it by Part D spending

About this data

A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.

A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.